GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Lanthanum Carbonate (Fosrenol, BAY77-1931) - chewable tablet

Company
Bayer
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Trial details
  • Completed NCT NCT01053676

    Bioequivalence Study of BAY77-1931 Granule

    Not yet reported Bayer 59 participants Est. completion 2010-04 1 site
    Other conditions: Hyperphosphatemia
    View official trial listing →
  • Completed NCT NCT01412398

    Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in Japan

    Bayer 446 participants Est. completion 2016-09-01 1 site
    Other conditions: Hyperphosphatemia
    View official trial listing →
  • Completed NCT NCT01419327

    Fosrenol Post-marketing Surveillance for Hemodialysis in Japan

    Bayer 3267 participants Est. completion 2019-05-28 1 site
    Other conditions: Hyperphosphatemia
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.